Citius Pharmaceuticals Inc.

05/25/2022 | Press release | Distributed by Public on 05/25/2022 06:52

Citius Pharmaceuticals, Inc. Announces Intention to Spinoff Late-Stage Oncology Asset, I/ONTAK, into a New Standalone Publicly Traded Company